%0 Journal Article
%@ 2296-2565
%A Sharif, Nadim
%A Sharif, Nazmul
%A Khan, Afsana
%A Halawani, Ibrahim F.
%A Alzahrani, Fuad M.
%A Alzahrani, Khalid J.
%A Díez, Isabel De la Torre
%A Ramírez-Vargas, Debora L.
%A Kuc Castilla, Ángel Gabriel
%A Parvez, Anowar Khasru
%A Dey, Shuvra Kanti
%D 2023
%F unic:9478
%J Frontiers in Public Health
%K long-COVID-19, comorbidity, diabetes, cardiovascular disease, Banglades
%T Prevalence and impact of long COVID-19 among patients with diabetes and cardiovascular diseases in Bangladesh
%U http://repositorio.unic.co.ao/id/eprint/9478/
%V 11
%X Introduction: Co-prevalence of long-COVID-19, cardiovascular diseases and diabetes is one of the major health challenges of the pandemic worldwide. Studies on long-COVID-19 and associated health outcomes are absent in Bangladesh. The main aim of this study was to determine the prevalence and impact of long-COVID-19 on preexisting diabetes and cardiovascular diseases (CVD) on health outcomes among patients in Bangladesh.  Methods: We collected data from 3,250 participants in Bangladesh, retrospectively. Multivariable logistic regression model was used to determine the odds ratio between independent and dependent variables. Kaplan-Meier survival curve was used to determine the cumulative survival.  Results: COVID-19 was detected among 73.4% (2,385 of 3,250) participants. Acute long-COVID-19 was detected among 28.4% (678 of 2,385) and chronic long-COVID-19 among 71.6% (1,707 of 2,385) patients. CVD and diabetes were found among 32%, and 24% patients, respectively. Mortality rate was 18% (585 of 3,250) among the participants. Co-prevalence of CVD, diabetes and COVID-19 was involved in majority of fatality (95%). Fever (97%), dry cough (87%) and loss of taste and smell (85%) were the most prevalent symptoms. Patients with co-prevalence of CVD, diabetes and COVID-19 had higher risk of fatality (OR: 3.65, 95% CI, 2.79–4.24). Co-prevalence of CVD, diabetes and chronic long-COVID-19 were detected among 11.9% patients.  Discussion: Risk of hospitalization and fatality reduced significantly among the vaccinated. This is one of the early studies on long-COVID-19 in Bangladesh.